Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for prevention of intraventricular hemorrhage complications in preterm newborns
IRCT20210607051507N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Intraventricular hemorrhage (IVH) comparing Acetazolamide with Placebo (2 arms). Primary endpoints: Duration of hospitalization, Change in grade of ventricular hemorrhage and 6 more. Started Sep 2021; status: completed.
02
Drugs
acetazolamide
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on IRCT20210607051507N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210607051507N3.